杏林製薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4569/E00985-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2021/09/24日証協無担保1,100株0%0株0%200株-98.59%
2021/09/24日証協有担保18,600株-64.64%53,000株+157.28%19,847株-71.76%
2021/09/17日証協無担保0株-100%0株0%14,200株+2740%
2021/09/17日証協有担保52,600株+69.13%20,600株-35.86%70,279株-69.7%
2021/09/10日証協無担保18,843株0%0株0%500株-68.75%
2021/09/10日証協有担保31,100株+53.2%32,117株+24%231,930株+169.93%
2021/09/03日証協無担保0株0%0株0%1,600株-83.84%
2021/09/03日証協有担保20,300株-49.75%25,900株-38.04%85,921株-19.48%
2021/08/27日証協無担保0株0%0株0%9,900株+16.47%
2021/08/27日証協有担保40,400株+3.94%41,800株-22.45%106,703株+213.83%
2021/08/20日証協無担保0株0%0株0%8,500株-30.33%
2021/08/20日証協有担保38,868株-45.89%53,900株+3.45%34,000株-9.05%
2021/08/13日証協無担保0株0%0株-100%12,200株+480.95%
2021/08/13日証協有担保71,832株+63.99%52,100株+24.94%37,382株+21.77%
2021/08/06日証協無担保0株-100%9,200株-87.67%2,100株+40%
2021/08/06日証協有担保43,803株+20%41,700株+93.95%30,700株-15.66%
2021/07/30日証協無担保100株-99.73%74,610株0%1,500株+275%
2021/07/30日証協有担保36,501株+381.42%21,500株+45.77%36,400株-0.82%
2021/07/21日証協無担保36,503株0%0株-100%400株-42.86%
2021/07/21日証協有担保7,582株-79.68%14,749株-25.12%36,700株-18.16%
2021/07/16日証協無担保0株0%1,400株0%700株-86%
2021/07/16日証協有担保37,320株+99.04%19,698株+130.39%44,844株-66.63%
2021/07/09日証協無担保0株0%0株-100%5,000株+1150%
2021/07/09日証協有担保18,750株-72.76%8,550株-80.05%134,380株+42.2%
2021/07/02日証協無担保0株-100%7,900株+393.75%400株+33.33%
2021/07/02日証協有担保68,840株-72.11%42,851株-70.73%94,500株-25.17%
2021/06/25日証協無担保3,000株+500%1,600株0%300株-70%
2021/06/25日証協有担保246,834株+44.02%146,400株+90.38%126,284株+739.15%
2021/06/18日証協無担保500株-64.29%0株-100%1,000株-62.96%
2021/06/18日証協有担保171,383株+25.28%76,900株-8.34%15,049株-81.92%
2021/06/11日証協無担保1,400株-54.84%1,000株0%2,700株-61.93%
2021/06/11日証協有担保136,800株+86.86%83,900株-40.98%83,240株+22.14%
2021/06/04日証協無担保3,100株-85.51%0株0%7,093株-16.55%
2021/06/04日証協有担保73,210株-78.84%142,161株+5.44%68,149株-11.9%
2021/05/28日証協無担保21,400株+1237.5%0株0%8,500株+240%
2021/05/28日証協有担保345,914株-30.26%134,821株+40.41%77,351株-39.57%
2021/05/21日証協無担保1,600株-80.17%0株0%2,500株-86.98%
2021/05/21日証協有担保495,982株-23.76%96,018株-11.47%128,011株-65.1%

※株式分割は考慮していませんのでご注意ください。

Page Top